Revvity beats quarterly results and raises annual guidance on life sciences growth
RVTY Revvity Inc
$154.39 -1.67%
View chart & analysis → - 1Revvity Inc adjusted EPS of $1.38 exceeded the consensus of $1.29.
- 2Revvity Inc revenue of $728.9 million beat expectations by 3.1%.
- 3Management raised annual guidance for the third consecutive time.
So what's the key point?
Revvity Inc performed better than experts expected due to strong earnings in the life sciences sector. Management raised their annual targets three times, showing the company's continued growth.
Source Earnings Whispers · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.